Caricamento...

MDM2, MDMX and p53 in oncogenesis and cancer therapy

The MDM2 and MDMX (also known as HDMX and MDM4) proteins are deregulated in many human cancers and exert their oncogenic activity predominantly by inhibiting the p53 tumour suppressor. However, the MDM proteins modulate and respond to many other signalling networks in which they are embedded. Recent...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wade, Mark, Li, Yao-Cheng, Wahl, Geoffrey M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161369/
https://ncbi.nlm.nih.gov/pubmed/23303139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc3430
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !